Fisher & Paykel Healthcare
$7.52 B
Share price
Change (1 day)
Change (1 year)

P/E ratio for Fisher & Paykel Healthcare (FPH.NZ)

P/E ratio at the end of 2022: 34.5

According to Fisher & Paykel Healthcare's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 47.5538. At the end of 2022 the company had a P/E ratio of 34.5.

P/E ratio history for Fisher & Paykel Healthcare from 2019 to 2022

PE ratio at the end of each year

Year P/E ratio Change

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.